ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

BIO Biotest AG

41.60
0.00 (0.00%)
19 Jul 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
Biotest AG TG:BIO Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 41.60 41.60 42.40 0.00 14:18:06

Relocation of Staff

23/05/2003 8:00am

UK Regulatory


RNS Number:4655L
BioFocus PLC
23 May 2003

BIOFOCUS PLC



23 MAY 2003



BioFocus to Consolidate Operations in Cambridge Area



BioFocus today announced its intention to consolidate the Sittingbourne
operation at its Chesterford Park location.



The consolidation will see the relocation of staff from its Sittingbourne
premises to Chesterford Park.  Operations on the Sittingbourne site will close
by the end of 2003.



Over the past 12 months, the company has looked at various options to bring its
operations together, including the building of a new facility.  The change in
the biotech property market has enabled BioFocus to negotiate Heads of Terms for
a 5-year lease on an existing building at Chesterford Park, which has become
available as a result of the downsizing of another company.  Consequently, the
cost of this exercise will be reduced from an anticipated #4-5m to less than
#1m.



The Company will continue to operate its Biology division from the existing
facility on the Cambridge Science Park.



Commenting on this, Geoff McMillan, Chief Executive, stated "The unanticipated
availability of suitable laboratory and office space next to our existing
premises at Chesterford Park presents a great opportunity to accelerate the
consolidation of our business into the Cambridge area.    It will also provide
sufficient growth potential and enable us to realise both scientific and
business synergies.  We will incur a one off restructuring and refurbishing
charge in 2003 which should not exceed #1m, however we will not now need to
incur the cost of building a new facility, as previously planned.  Operating
costs will also be held at current levels."



Enquires:


BioFocus Plc                         01799 533500
Stephen France



END


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCUUVNROSRVUAR

1 Year Biotest Chart

1 Year Biotest Chart

1 Month Biotest Chart

1 Month Biotest Chart

Your Recent History

Delayed Upgrade Clock